EM

Elizabeth Mulligan

Director Of Product Development at Elephas

Elizabeth Mulligan has extensive experience in product development and project management within the biotechnology industry. Elizabeth currently holds the position of Director of Product Development at Elephas, a role they started in October 2022. Prior to this, they worked at Exact Sciences from September 2018 to October 2022, holding the position of Sr. Director, R&D Project Management.

Before joining Exact Sciences, Mulligan worked at Luminex Corporation from 2011 to 2018, where they held various roles within the product development department. These roles included Senior Director, Product Development from April 2016 to September 2018, Director of Product Development from November 2012 to March 2016, and Senior Manager of Product Development from June 2011 to October 2012.

Mulligan's earlier work experience includes positions at EraGen Biosciences, where they worked from 2005 to 2011. During this time, they held the role of Manager of Product Development from September 2008 to June 2011, Scientist II from April 2007 to September 2008, and Scientist I from April 2005 to April 2007.

Elizabeth Mulligan completed their Bachelor's degree in Biochemistry at The College of Wooster from 1994 to 1998. Elizabeth continued their education at the University of Wisconsin-Madison, where they obtained a Doctor of Philosophy (PhD) in Biochemistry from 1998 to 2005.

Location

Middleton, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Elephas

Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodalmicroscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.


Industries

Employees

51-200

Links